Antibacterial Agents TRIZ Cases

A backbone-cyclized peptide combines with antibiotics to achieve synergistic antimicrobial activity.

Multicomponent staphylococcal vaccine antigens overcome bacterial immune evasion mechanisms to provide effective prevention against S. aureus infections.

Aluminum chelation conjugates 18F to peptides, replacing HPLC purification with filtration to reduce process time.

Str-PAP-1 bacteriophage composition prevents Streptococcus parauberis infections by destroying bacterial cell walls, avoiding antibiotic resistance.

Oral DNase administration overcomes poor absorption barriers, enabling systemic DNA destruction for inflammatory and tumorous conditions.

Cyclic peptidomimetic compounds resolve antibody potency limits by selectively blocking PD-1, PD-L1, or PD-L2 to suppress immunosuppressive signals.

Replacing citric acid with succinic acid prevents chemical degradation of tedizolid phosphate powder for suspension.

A plant fat composition using enzymatically trans-esterified palm oil to reduce transepidermal water loss.

Conditioned plasma from incubated whole blood inhibits bacterial growth without triggering resistance or allergic reactions.

Arylsulfonohydrazide inhibitors target MurC and MurD enzymes, blocking peptidoglycan synthesis to treat antibiotic-resistant bacteria.

Novel MreB inhibitor compounds target essential bacterial proteins to disrupt cell shape maintenance and chromosome segregation.

Modifying thiopeptide structures inhibits EF-Tu activity, treating multidrug-resistant Gram-positive bacteria.

Purified capsule polysaccharide antigens eliminate lipooligosaccharide contaminants, preventing autoimmune responses while maintaining broad serotype coverage.

Shortened finafloxacin regimens eradicate urinary tract pathogens without increasing daily dosages, reducing antibiotic resistance risks.

Engineered DVD proteins use self-sorting domain interfaces to eliminate molecular heterogeneity and reduce immunogenicity in bispecific antibody production.

Phosphonates enable 45-65 wt% alcohol formulations to inactivate poliovirus while reducing flammability and material damage.

Optimized calcium phosphate composition yields moderate hardness for ultrasonic removal without toxic solvents.

Nitrogen-containing heterocyclic substituted benzoxazine oxazolidinone compounds target Mycobacterium tuberculosis with potent activity.

Adenosine receptor agonists with pH-dependent affinity target acidic pathological tissues, minimizing hypotension and tachycardia side effects.

CpG rich DNA compositions activate immune responses to treat cancer.

Tamoxifen inhibits Shiga toxin transport by altering endosomal dynamics, resolving the limitation of existing inhibitors that only target STx1.

Engineered peptide linkers in dual variable domain immunoglobulins enable controlled heavy and light chain pairing, reducing molecular heterogeneity.

Peptide p2TA binds bacterial superantigens to block inflammatory cytokine induction, reducing systemic toxicity and mortality in severe infections.

Fermented herbal vaginal capsule inhibits Gardnerella vaginalis and promotes beneficial microbiota to resolve drug resistance and recurrence.

An engineered Fc variant binds the inhibitory FcγRIIb receptor with high affinity to suppress B cell activation signals.

Disulfide-modified polymyxin analogues reduce nephrotoxicity while retaining efficacy against Gram-negative bacterial infections.

Naphthyridine derivatives inhibit MEK and ERK activity to treat hyperproliferative disorders via parameter changes.

Fused tricyclic compounds overcome antibiotic resistance by delivering broad-spectrum efficacy against bacteria, viruses, and fungi.

Liposome-delivered plasmids with CpG motifs trigger immediate innate immunity, resolving the delay in conventional vaccine protection.